This novel compound is currently undergoing laboratory investigation. The success of growth-hormone-receptor antagonists in treating unresolved acromegaly is very encouraging for speculating on ...
Many of these OXT and vasopressin binding-independent activities have involved a parallel expansion on the roles of known cellular components; among these are β-arrestins, cholesterol, and steroid ...
Sep. 4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay ...
Kidney stones are among the possible risks of GLP-1 use that were not previously known. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have a wider range of benefits and risks than what the ...
HealthDay News — For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including ...